Spondyloenchondrodysplasia Latest Advances
Find the Latest Research About Spondyloenchondrodysplasia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
A Multicenter Integrative Cohort Characterizing the Genetic, Clinical, and Transcriptomic Features of ACP5 Deficiency.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2026
Janus kinase inhibitor therapy for the treatment of spondyloenchondrodysplasia with immune dysregulation due to novel ACP5 variants: a multicenter study.
Journal: Frontiers in immunology
Published: January 15, 2026
Monogenic lupus secondary to spondyloenchondrodysplasia with immune dysregulation.
Journal: Joint bone spine
Published: December 18, 2025
Oral and Craniofacial Development and Immunology.
Journal: Advances in experimental medicine and biology
Published: November 12, 2025
Spondyloenchondrodysplasia: An enigmatic immuno-osseus type I interferonopathy.
Journal: Journal of human immunity
Published: October 06, 2025
Genetic Diseases Mimicking Rheumatic Disorders: Insights From Southeastern Turkey.
Journal: American journal of medical genetics. Part A
Published: April 18, 2025
Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases.
Journal: Frontiers in pharmacology
Published: March 24, 2025
Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation.
Journal: Journal of clinical immunology
Published: March 19, 2025
Spondyloenchondrodysplasia with immune dysregulation: an under-the-radar cause of spasticity.
Journal: Journal of Yeungnam medical science
Published: March 08, 2025
Last Updated: 09/26/2026